One-carbon metabolism gene polymorphisms and risk of non-Hodgkin lymphoma in Australia

Human Genetics

Volumn 122, Issue 5, 2007, Pages 525-533

  Lee, Kyoung Mu ^a   Lan, Qing ^a   Kricker, Anne ^a   Purdue, Mark P ^a   Grulich, Andrew E ^c   Vajdic, Claire M ^c   Turner, Jennifer ^d   Whitby, Denise ^e   Kang, Daehee ^f   Chanock, Stephen ^g   Rothman, Nathaniel ^a   Armstrong, Bruce K ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d ST VINCENT S HOSPITAL   (Australia)

^e NATIONAL CANCER INSTITUTE   (United States)

^f Seoul National University College of Medicine   (South Korea)

^g Advanced Technology Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHYLTETRAHYDROFOLATE HOMOCYSTEINE METHYLTRANSFERASE; 5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CARRIER PROTEIN; CYSTATHIONINE BETA SYNTHASE; FOLYLPOLYGLUTAMATE SYNTHASE; FORMATE TETRAHYDROFOLATE LIGASE; GLYCINE HYDROXYMETHYLTRANSFERASE; HAPTOCORRIN; METHYLENETETRAHYDROFOLATE DEHYDROGENASE; SOLUTE CARRIER PROTEIN 19A1; THYMIDYLATE SYNTHASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AUSTRALIA; B CELL LYMPHOMA; CANCER RISK; CARBON METABOLISM; CARCINOGENESIS; CAUCASIAN; CONTROLLED STUDY; FEMALE; FOLLICULAR LYMPHOMA; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HIGH RISK POPULATION; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ALLELES; AUSTRALIA; CARBON; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, NON-HODGKIN; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 36348966549     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00439-007-0431-2     Document Type: Article

References (42)

1. Anguera MC, Field MS, Perry C, Ghandour H, Chiang EP, Selhub J, Shane B, Stover PJ (2006) Regulation of folate-mediated one-carbon metabolism by 10-formyltetrahydrofolate dehydrogenase. J Biol Chem 281(27):18335-18342
2. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088-1101
3. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc B289-B300
4. Blount BC, Mack MM, Wehr CM, MacGregor JT, Hiatt RA, Wang G, Wickramasinghe SN, Everson RB, Ames BN (1997) Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA 94(7):3290-3295
5. Chapman JM, Cooper JD, Todd JA, Clayton DG (2003) Detecting disease associations due to linkage disequilibrium using haplotype tags: A class of tests and the determinants of statistical power. Hum Hered 56(1-3):18-31
6. Curran-Everett D (2000) Multiple comparisons: Philosophies and illustrations. Am J Physiol Regul Integr Comp Physiol 279(1):R1-R8
7. Das PM, Singal R (2004) DNA methylation and cancer. J Clin Oncol 22(22):4632-4642
8. Deligezer U, Akisik EE, Yaman F, Erten N, Dalay N (2006) MTHFR C677T gene polymorphism in lymphoproliferative diseases. J Clin Lab Anal 20:37-41
9. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634
10. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, den Heijer M, Kluijtmans LAJ, van den Heuvel LP, Rozen R (1995) A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113
11. Gemmati D, Ongaro A, Scapoli GL, Porta MD, Tognazzo S, Serino ML, Bona ED, Rodeghiero F, Gilli G, Reverberi R, Garuso A, Pasello M, Pellati A, Mattei MD (2004) Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgikin's lymphoma in adults. Cancer Epidemiol Biomarkers Prev 13(5):787-794
12. Gonzalez Ordonez AJ, Fernandez Carreira JM, Fernandez Alvarez CR, Martin L, Sanchez Garcia J, Medina Rodriguez JM, Alvarez MV, Coto E (2000) Normal frequencies of the C677T genotypes on the methylenetetrahydrofolate reductase (MTHFR) gene among lymphoproliferative disorders but not in multiple myeloma. Leuk Lymphoma 39(5-6):607-612
13. Habib EE, Aziz M, Kotb M (2005) Genetic polymorphism of folate and methionine metabolizing enzymes and their susceptibility to malignant lymphoma. J Egypt Natl Canc Inst 17(3):184-192
14. Hanada M, Delia D, Aiello A, Stadtmauer E, Reed JC (1993) Bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood 82(6):1820-1828
15. Hartge P, Wang SS (2004) Overview of the etiology and epidemiology of lymphoma. In: Mauch PM, Armitage JO, Coiffier B, Dalla-Favera R, Harris NL (eds) Non-Hodgkin's lymphomas. Lippincott, Philadelphia, pp 711-727
16. Hishida A, Matsuo K, Hamajima N, Ito H, Ogura M, Kagami Y, Taji H, Morishima Y, Emi N, Tajima K (2003) Associations between polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and susceptibility to malignant lymphoma. Haematologica 88(2):159-166
17. Hughes AM, Armstrong BK, Vajdic CM, Turner J, Grulich A, Fritschi L, Milliken S, Kaldor J, Benke G, Kricker A (2004) Pigmentary characteristics, sun sensitivity and non-Hodgkin lymphoma. Int J Cancer 110(3):429-434
18. Kim YI (2005) 5,10-Methylenetetrahydrofolate reductase polymorphisms and phamacogenetics: A new role of single nucleotide polymorphisms in the folate metabolic pathway in human health and disease. Nutr Rev 63(11):398-407
19. Krupenko SA, Oleinik NV (2002) 10-formyltetrahydrofolate dehydrogenase, one of the major folate enzymes, is down-regulated in tumor tissues and possesses suppressor effects on cancer cells. Cell Growth Differ 13(5):227-236
20. Kuppers R (2005) Mechanisms of B-cell lymphoma pathogenesis. Nat Rev Cancer 5(4):251-262
21. Ladner RD (2001) The role of dUTPase and uracil-DNA repair in cancer chemotherapy. Curr Protein Pept Sci 2(4):361-370
22. Lightfoot TJ, Skibola CF, Willett EV, Skibola DR, Allan JM, Coppede F, Adason PJ, Morgan GJ, Roman E, Smith MT (2005) Risk of non-Hodgkin lymphoma associated with polymorphisms in folate-metabolizing genes. Cancer Epidemiol Biomarkers Prev 14(12):2999-3003
23. Lim U, Wang SS, Hartge P, Cozen W, Kelemen LE, Chanock S, Davis S, Blair A, Schenk M, Rothman N, Lan Q (2007) Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER Case-Control Study. Blood 109(7):3050-3059
24. Lincz LF, Scorgie FE, Kerridge I, Potts R, Spencer A, Enno A (2003) Methionine synthase genetic polymorphism MS A2756G alters susceptibility to follicular but not diffuse large B-cell non-Hodgkin's lymphoma or multiple myeloma. Br J Haematol 120(6):1051-1054
25. Linnebank M, Schmidt S, Kolsch H, Linnebank A, Heun R, Schmidt-Wolf IGH, Glasmacher A, Fliessbach K, Klockgether T, Schlegel U, Pels H (2004) The methionine synthase polymorphism D919G alters susceptibility to primary central nervous system lymphoma. Br J Cancer 90:1969-1971
26. Mandola MV, Stoehlmacher J, Zhang W, Groshen S, Yu MC, Iqbal S, Lenz HJ, Ladner RD (2004) A 6 bp polymorphism in the thymidylate synthase gene causes message instability and is associated with decreased intratumoral TS mRNA levels. Pharmacogenetics 14(5):319-327
27. Matsuo K, Suzuki R, Hamajima N, Ogura M, Kagami Y, Taji H, Kondoh E, Maeda S, Asakura S, Kaba S, Nakamura, Seto M, Morishima Y, Tajima K (2001) Association between polymorphisms of folate- and methionine-metabolizing enzymes and susceptibility to malignant lymphoma. Blood 97(10):3205-3209
28. Matsuo K, Hamajima N, Suzuki R, Ogura M, Kagami Y, Faji H, Yasue T, Mueller NE, Nakamura S, Seto M, Morishima Y, Jajima K (2004) Methylenetetrahydrofolate reductase gene (MTHFR) polymorphisms and reduced risk of malignant lymphoma. Am J Hematol 77:351-357
29. Niclot S, Pruvot Q, Besson C, Savoy D, Macintyre E, Salles G, Brousse N, Varet B, Landais P, Taupin P, Junien C, Baudry-Bluteau D (2006) Implication of the folate-methionine metabolism pathways in susceptibility to follicular lymphomas. Blood 108(1):278-285
30. Packer BR, Yeager M, Burdett L, Welch R, Beerman M, Qi L, Sicotte H, Staats B, Acharya M, Crenshaw A, Eckert A, Puri V, Gerhard DS, Chanock SJ (2006) SNP500Cancer: A public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucleic Acids Res 34:D617-D621
31. Pereira TV, Rudnicki M, Pereira AC, Pombo-de-Oliveira MS, Franco RF (2006) 5,10-Methylenetetrahydrofolate reductase polymorphisms and acute lymphoblastic leukemia risk: A meta-analysis. Cancer Epidemiol Biomarkers Prev 15(10):1956-1963
32. Purdue MP, Lan Q, Kricker A, Grulich AE, Vajdic CM, Turner J, Whitby D, Chanock S, Rothman N, Armstrong BK (2007) Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: Findings from the New South Wales non-Hodgkin lymphoma study. Carcinogenesis 28(3):704-712
33. Reuland SN, Vlasov AP, Krupenko SA (2006) Modular organization of FDH: Exploring the basis of hydrolase catalysis. Protein Sci 15(5):1076-1084
34. Rossi D, Capello D, Gloghini A, Franceschetti S, Paulli M, Bhatia K, Saglio G, Vitolo U, Pileri SA, Esteller M, Carbone A, Gaidano G (2004) Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia. Haematologica 89(2):154-164
35. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70(2):425-434
36. Shen M, Rothman N, Berndt SI, He X, Yeager M, Welch R, Chanock S, Caporaso N, Lan Q (2005) Polymorphisms in folate metabolic genes and lung cancer risk in Xuan Wei, China. Lung Cancer 49(3):299-309
37. Skibola CF, Forrest MS, Coppede F, Agana L, Hubbard A, Smith MT, Bracci PM, Holly EA (2004) Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma. Blood 104(7):2155-2162
38. Sterne JA, Bradburn MJ, Egger M (2001) Meta-analysis in Stata. In: Egger M, Davey Smith G, Altman D (eds) Systematic reviews in health care, 2nd edn, vol 2. Blackwell BMJ Books, Boston, pp 347-369
39. Timuragaoglu A, Dizlek S, Uysalgil N, Tosun O, Yamac K (2006) Methylenetetrahydrofolate reductase C677T polymorphism in adult patients with lymphoproliferative disorders and its effect on chemotherapy. Ann Hematol 85(12):863-868
40. Toffoli G, Rossi D, Gaidano G, Cecchin E, Boiocchi M, Carbone A (2003) Methylenetetrahydrofolate reductase genotype in diffuse large B-cell lymphomas with and without hypermethylation of the DNA repair gene O6-methylguanine DNA methyltransferase. Int J Biol Markers 18(3):218-221
41. Turner JJ, Hughes AM, Kricker A, Milliken S, Grulich A, Kaldor J, Armstrong B (2004) Use of the WHO lymphoma classification in a population-based epidemiological study. Ann Oncol 15(4):631-637
42. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N (2004) Assessing the probability that a positive report is false: An approach for molecular epidemiology studies. J Natl Cancer Inst 96(6):434-442